Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphoma (Q86636858)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Federica Galaverna

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Laura Giordano

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Luca Castagna

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

A Raiola

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A Dominietto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A Ghiso

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S Bramanti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

E Todisco

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

B Sarina

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A Ibatici

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A Santoro

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M Clavio

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A Bacigalupo

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

4 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

190-194

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24185585%20AND%20SRC:MED&resulttype=core&format=json

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

29 February 2020

cites work

1 reference

12 December 2020

Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial

1 reference

12 December 2020

Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement

1 reference

12 December 2020

High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience

1 reference

12 December 2020

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1 reference

12 December 2020

Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma

1 reference

12 December 2020

Cyclophosphamide and cancer: golden anniversary

1 reference

12 December 2020

Immune-mediated attack in relapsed Hodgkin's lymphoma

1 reference

12 December 2020

1 reference

12 December 2020

Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation

1 reference

12 December 2020

Allogeneic transplantation for Hodgkin's lymphoma

1 reference

12 December 2020

Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry

1 reference

12 December 2020

Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.

1 reference

12 December 2020

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

1 reference

12 December 2020

Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma.

1 reference

12 December 2020

Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability

1 reference

12 December 2020

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

1 reference

12 December 2020

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

1 reference

12 December 2020

Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin's lymphoma.

1 reference

12 December 2020

Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome

1 reference

12 December 2020

Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol

1 reference

12 December 2020

Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up

1 reference

12 December 2020

Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality

1 reference

12 December 2020

Reduced-intensity allogeneic transplantation in patients with refractory or progressive Hodgkin's disease after high-dose chemotherapy and autologous stem cell infusion

1 reference

12 December 2020

Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

1 reference

12 December 2020